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Abstract
Background: There is limited evidence for the clinical and cost effectiveness of occupational therapy (OT)
approaches in the management of hand osteoarthritis (OA). Joint protection and hand exercises have been
proposed by European guidelines, however the clinical and cost effectiveness of each intervention is unknown.
This multicentre two-by-two factorial randomised controlled trial aims to address the following questions:
• Is joint protection delivered by an OT more effective in reducing hand pain and disability than no joint
protection in people with hand OA in primary care?
• Are hand exercises delivered by an OT more effective in reducing hand pain and disability than no hand
exercises in people with hand OA in primary care?
• Which of the four management approaches explored within the study (leaflet and advice, joint protection, hand
exercise, or joint protection and hand exercise combined) provides the most cost-effective use of health care
resources
Methods/Design: Participants aged 50 years and over registered at three general practices in North Staffordshire
and Cheshire will be mailed a health survey questionnaire (estimated mailing sample n = 9,500). Those fulfilling the
eligibility criteria on the health survey questionnaire will be invited to attend a clinical assessment to assess for the
presence of hand or thumb base OA using the ACR criteria. Eligible participants will be randomised to one of four
groups: leaflet and advice; joint protection (looking after your joints); hand exercises; or joint protection and hand
exercises combined (estimated n = 252). The primary outcome measure will be the OARSI/OMERACT responder
criteria combining hand pain and disability (measured using the AUSCAN) and global improvement, 6 months
post-randomisation. Secondary outcomes will also be collected for example pain, functional limitation and quality
of life. Outcomes will be collected at baseline and 3, 6 and 12 months post-randomisation. The main analysis will
be on an intention to treat basis and will assess the clinical and cost effectiveness of joint protection and hand
exercises for managing hand OA.
Discussion: The findings will improve the cost-effective evidence based management of hand OA.
Trial registration: identifier: ISRCTN33870549
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Background
Osteoarthritis (OA) is the commonest form of arthritis in
the UK. It is the source of most of the musculoskeletal
pain and disability in adults aged 50 years and over [1] and
the hand is one of the most common sites of pain and
osteoarthritic change in this age-group [2,3]. In a large
cross-sectional survey of older adults with musculoskeletal
hand problems in North Staffordshire, participants
reported significant hand pain and disability, which
affected their everyday lives [4]. The majority of people
with hand OA are managed in primary care but often core
treatments recommended by European and UK guidelines
are not given [5] and patients report dissatisfaction with
management [6]; ‘I went to the GP (he) gave me a form...
with osteoarthritis or something, whatever they call it. I
thought that wasn’t very helpful. ‘Nothing we can do
about it’ he said and at the time I’d got really bad pain,
which was why I went.... down the thumb. I honestly
wouldn’t ever go back and tell them my hands are playing
up ‘cause he said there was nothing they could do’ [6]. As
a consequence few people with hand problems visit their
general practitioner (GP), even when severely affected [4],
and even fewer attend for occupational therapy (OT) [7].
In our survey, only 3% of those with severe disability
reported seeing an occupational therapist (OT) in the last
year [4] despite the fact that OTs commonly deliver core
treatments for people with hand OA.
Joint protection and hand exercises are core compo-
nents of OT. Joint protection aims to reduce pain, disabil-
ity and improve function through the use of ergonomic
approaches such as altering movement patterns, modifica-
tion of task and environment, and use of assistive devices
[8]. Patients are helped to understand how strain on the
joint when carrying out daily activities can contribute to
joint pain and potentially promote joint deformity. Hand
exercises also aim to reduce pain and disability, and
improve physical functioning and grip strength [9]. Studies
in patients with lower limb OA suggest that exercise ther-
apy may delay or even prevent the onset of disease [10]
although its effectiveness in hand OA is still uncertain.
Increasingly, OTs use educational-behavioural
approaches to enhance the use of self-management and
behaviour change interventions such as exercise and
joint protection [8,11,12]. Goal-setting and problem-sol-
ving, with adequate time to practice new skills in order
to develop new habits and routines, are used to facilitate
uptake of exercise and joint protection techniques
[11,12].
Despite the fact that joint protection and hand exer-
cises are frequently used by OTs and physiotherapists
(PTs) in the management of hand OA, and have been
recommended for all patients in the European League
Against Rheumatism (EULAR) recommendations [13],
systematic reviews conclude there is a paucity of evi-
dence to support these interventions [14-16]. One trial
in secondary care demonstrated modest benefits of joint
protection plus hand exercises compared with an educa-
tion leaflet for hand OA [17]. A study of yoga exercises
in a hand OA population has shown promising findings
[18].
The EULAR recommendation to provide joint protec-
tion and hand exercises for all patients with hand OA is
based largely on expert opinion and has not been evalu-
ated in high quality randomised controlled trials. The
majority of patients with hand OA will be managed in
primary care and it is therefore important to evaluate
the benefits of hand exercises and joint protection
before the EULAR recommendations can be adopted in
this setting. This paper outlines the protocol for the Self
Management in Osteoarthritis of the Hand (SMOotH)
trial.
Trial development
The trial was designed with key stakeholders: OTs with
experience of treating patients with hand OA, and
research users with experience of living with or caring
for someone with hand OA.
Occupational Therapists
We have established a clinical advisory group of 10 OTs
working in hand therapy and musculoskeletal conditions
in North Staffordshire and Central Cheshire, UK. The
group helped develop the research questions, interven-
tions and the trial design. We have used this approach
successfully in previous studies of physiotherapy [19,20].
The OT clinical advisory group was consulted at all
stages of the study development through four half-day
workshops, and identified the research questions as
important to current clinical practice. These workshops
considered the current best evidence for the manage-
ment of hand OA using critically appraised topics [21].
User involvement
In the UK there is a clear policy directive to involve
patients and the public in research [22]. Such involve-
ment is thought to lead to research which is of clinical
relevance and of better quality [23-26]. We have an
established Research User Group and Virtual User Panel
who provide advice and feedback on trial conduct and
offer patient representation on the trial steering groups.
We will engage both OTs and Research Users
throughout each stage of the trial.
Trial Objectives
Specifically, our study will consider the following main
research questions:
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• Is joint protection delivered by an OT more effective
in reducing hand pain and disability than no joint pro-
tection in people with hand OA in primary care?
• Are hand exercises delivered by an OT more effec-
tive in reducing hand pain and disability than no hand
exercises in people with hand OA in primary care?
• Which of the four management approaches explored
within the study (leaflet and advice, joint protection,
hand exercise, or joint protection and hand exercise
combined) provides the most cost-effective use of health
care resources
These research questions are in line with recommen-
dations of the EULAR guidelines for the management of
hand OA [13]. The study has been designed to meet the
Osteoarthritis Research Society International (OARSI)
recommendations for clinical trials in hand OA [27].
Methods/Design
This is a multicentre two-by-two factorial randomised
controlled trial in community-dwelling older adults of
non-pharmacological interventions [28] with a superior-
ity design [29]. Participants will be allocated to one of
four groups: leaflet and advice; a joint protection pro-
gramme; a hand exercise programme; or a joint protec-
tion and hand exercise programme (see Table 1).
Participants
All participants aged 50 years and over registered with 3
general practices in Central Cheshire and North Stafford-
shire (estimated n = 9,500) will be mailed a health survey
questionnaire asking about their general health and any
hand pain or hand problems experienced for a day or
longer over the past 12 months. Prior to mailing, general
practitioners (GPs) will have the opportunity to screen the
participant list for any exclusions e.g. vulnerable adults,
those with psychiatric illness. Immediately prior to mail-
ing, a deaths and departure check will be completed to
verify that participants are still registered at the GP prac-
tice and have not recently died or left the practice. To
avoid contamination between participants only one person
for each address will be considered eligible for the study.
This will avoid any contamination of interventions
between individuals in the same household. The first per-
son from the household to respond to the survey will be
deemed eligible.
All participants responding to the health survey ques-
tionnaire will be screened for eligibility. Those who meet
the eligibility screen (see Table 2) will be contacted by
post with a letter outlining the trial, a further study infor-
mation sheet, and an invitation to telephone the research
centre should they wish to attend for clinical assessment.
Those who wish to take part will be asked to make an
appointment to have a brief clinical assessment by a
research nurse, undertake a further phase of eligibility
screening (see Table 3) and a face-to-face consent proce-
dure. At the end of the clinic, details of eligible partici-
pants will be forwarded to the research centre and
participants will be randomised to one of four groups: leaf-
let and advice; joint protection (looking after your joints);
hand exercises; or a combined intervention of joint protec-
tion and hand exercises.
Eligibility criteria
Participants included in the trial will be aged 50 years and
over identified from general practice registers. Eligibility
criteria for each stage of the study are based on the recom-
mendations of the OARSI task force on design and con-
duct of clinical trials in hand OA [27]. Inclusion criteria
are: males and females; aged 50 years and over; fulfilling
the American College of Rheumatology (ACR) definition
of symptomatic hand osteoarthritis [27,30], or sympto-
matic thumb base OA on clinical assessment; no other
household member participating in the trial; ability to
understand and capable of giving written informed con-
sent. Exclusion criteria are: consultation or treatment for
this hand problem in the previous 6 months including an
intra-articular joint injection to wrist, fingers or thumb,
fractures or significant injury or surgery to the wrist or
hand [27]; consultation for this hand problem with an
occupational therapist or physiotherapist; red flags, e.g.
history of serious illness or disease (e.g. stroke), progres-
sive neurological signs, acute swollen joint; those with a
diagnosis of inflammatory arthritis (e.g. rheumatoid arthri-
tis (RA), psoriatic arthritis); minimal pain and function on
the Australian/Canadian hand outcome score (AUSCAN)
[31] pain < 5 and function < 9) [27]. Individuals with co-
existing hand conditions, such as carpal tunnel syndrome,
Dupuytrens contracture, trigger finger, will not be
excluded unless the condition is deemed at the clinic to be
the primary cause of the hand problem.
Table 1 Two by two factorial randomised trial: leaflet and advice, joint protection, hand exercises, joint protection
and hand exercises
Leaflet and advice alone Joint protection
Leaflet and advice alone Leaflet and advice Leaflet and advice
Joint protection
Hand exercises Leaflet and advice
Hand exercises
Leaflet and advice
Hand exercises and joint protection
Rows and column headings indicate possible interventions, cells indicate the four possible treatment allocations.
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Clinic assessment procedures
Invitation to the clinic
Respondents to the health survey questionnaire who
meet the eligibility criteria and provide written consent
to further contact will be sent a letter of invitation and
a study participant information sheet outlining the
SMOotH Study and the details of reimbursement for
their travel to the clinic. Non-responders will be sent a
reminder invitation two weeks later. Those willing to
take part in the study will be booked into the next con-
venient appointment for the assessment clinic and a let-
ter of confirmation and baseline SMOotH questionnaire
mailed. The assessment clinic is expected to last
approximately one hour. Participants’ baseline question-
naire will be checked for completion by the research
nurse at the clinic assessment.
Participants who do not attend clinic for their speci-
fied appointment will be sent another letter asking them
to re-contact the research centre and to book another
appointment if they still wish to participate.
On arrival at the clinic the study will be discussed
with participants and written informed consent taken
prior to assessment and randomisation.
Prior to assessment, all participants will undertake
screening to identify possible red flags indicative of
potentially serious pathology, e.g. recent trauma to the
hands likely to have resulted in significant tissue
damage, and acutely swollen and painful hand joints.
Further screening will be carried out to determine
whether the participants meet the eligibility criteria (see
Table 3). This will include examination of the hand
joints for features of hand OA using the ACR Classifica-
tion and whether the participant has thumb base OA.
Participants’ availability to attend OT sessions in the
next 3 months will be ascertained.
Participants who consent to participate in the study
and meet the eligibility criteria will be invited to under-
take a research interview and hand function assessment
with a research nurse [32,33]. Assessment equipment
(Jamar Dynamometer and B&L Pinch Gauge [33]) will
be calibrated prior to the start of the study.
Irrespective of whether they are randomised, all parti-
cipants attending the clinic will receive out of pocket
expenses, an information leaflet and advice. Those who
do not consent to be part of the trial or are ineligible
will be asked for their consent to use the information
already provided for the study and given advice to con-
sult their GP if their hand problems continue to be
troublesome. Consent forms and assessment documen-
tation will be placed in secure storage at the research
centre.
The GP will be notified whether the participant has
been recruited to the trial. Any significant abnormalities
identified in the clinic will be communicated to their
GP via a post-clinic fax and letter.
Participant timeline
Participant flow can be seen in Figure 1. Follow-up will
be at 3 months, 6 months and 12 months after rando-
misation to evaluate short, medium and longer-term
outcome. Six-months after attending the baseline
Table 2 Eligibility criteria assessed on the health survey questionnaire
Participants will be eligible to be invited to the baseline nurse clinical assessment if they meet the following criteria on the health survey
questionnaire:
• Give consent to further contact
• Report hand pain in the last 12 months
• Report hand pain aching or stiffness on “some days”, “most days” or “all days” in the last month
• Have an AUSCAN pain score > = 5 or an AUSCAN function score > = 9
• Report they have not:
a. seen an occupational or physiotherapist for their hand in the last 6 months
b. injured their hands badly enough to see a doctor in the last 6 months
c. had any hand operations in the last 6 months
d. had any hand injections in the last 6 months
• No other household member is participating in the trial
Table 3 Eligibility criteria assessed by the research nurse at the baseline nurse clinical assessment
Participants will be randomised to the trial if they meet the following criteria at the baseline nurse clinical assessment:
• Give informed consent to participate in the trial
• Meet the ACR criteria for features of hand OA (symptoms previously assessed on health survey) or have unilateral or bilateral thumb base OA
• Do not have a clinical “red flag” indicative of potentially serious pathology
• Able to attend OT classes
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assessment clinic, randomised participants will receive a
self-administered questionnaire and an invitation to
attend a brief clinical assessment of hand functional per-
formance by a research nurse, using the same proce-
dures as at baseline. The 3- and 12-month follow-up
will be undertaken by self-administered postal question-
naire alone.
Trial Procedures
Recruitment and retention strategies
Standard research centre procedures will be followed to
maximise follow up. Non-responders to the health sur-
vey will receive a postcard reminder at 2 weeks followed
by a second questionnaire 2 weeks later. If there is still
no response, no further contact will be made. At 3- and
 
 
Mailed invitation to attend 
clinical assessment  
Adults aged 50 years and over 
registered with 3 GP practices  
Screening questionnaire 
returned and assessed for trial 
eligibility  
Eligible sample for 
randomisation 
Clinical assessment attended 
and baseline questionnaire 
completed 
Screening questionnaire 
mailed 
Exclude by GP after 
screening participant list  
Exclude: Non-
response/refused 
screening questionnaire  
Exclude: Did not meet 
eligibility criteria (table 2) 
Non-response/ did not want 
or unable to attend clinical 
assessment 
Did not meet eligibility 
criteria at clinical 
assessment (table 3) 
Leaflet and advice Joint protection Hand exercises Both 
3-month postal questionnaire 
6-month postal questionnaire (including diary) and clinic assessment 
12-month postal questionnaire 
No further contact 
with research 
centre 
Receive leaflet 
and advice   
Advised to see 
GP if symptoms 
continue to be 
troublesome  
No further contact 
with research 
centre  
Receive leaflet and advice 
intervention  
Receive baseline diary for 
completion at home 
GP informed of 
participants’ study 
involvement  
Randomisation 
Figure 1 Recruitment flow chart.
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12-month follow-up, randomised participants will
receive postcard reminders and follow-up question-
naires. Non-responders will be approached for Mini-
mum Data Collection (MDC) 2-weeks after the second
questionnaire is mailed. MDC is a shorter version of the
health survey questionnaire and will be used to collect
the primary outcome measure (OARSI/OMERACT
responder criteria) along with date of birth, age and
gender to ensure the data are provided by the intended
participant. MDC is completed on the telephone, or by
post where consent to telephone contact has not been
given. The reminder process for baseline and 6 month
nurse clinic attendance will include an initial invitation
to attend the clinic, and a reminder sent two weeks
later. At 6-months, if there is still no response, the fol-
low-up questionnaire will be mailed to participants but
without an invitation to attend the clinical assessment.
If there is still no response after a further 2 weeks,
MDC will be completed if possible. Participants failing
to attend an assessment appointment will be offered a
second appointment. At all stages of the trial, any rea-
son for non-participation will be recorded, if given.
Consent
Only participants giving consent to further contact on the
health survey questionnaire will be mailed an invitation to
attend the baseline nurse clinical assessment. Face-to-face
consent will also be obtained by the research nurse at the
baseline clinical assessment. This consent procedure
includes consent to receive follow-up mailings, randomisa-
tion to one of four treatment approaches and to attend a
follow-up assessment clinic at 6 months. The research
nurse will also ask participants if they give consent for the
research team to access their medical records. If they do,
their medical records will be tagged using an electronic
computer system, to support a later review of consultation
records. Participants will be informed of the right to with-
draw from the study at any time and for any reason with-
out prejudice to future care. Participants will not receive
any further mailings if they wish to withdraw from the
study at any time.
Confidentiality
Participants will be assured of confidentiality and parti-
cipant details will not be made available to anyone out-
side the study team. GPs will be informed of their
patients’ willingness to be part of the study and their
agreement for their inclusion will be ascertained. All
participants excluded from entry into the trial at any
stage will be offered standard information, on request,
by the Principal Investigator and advised to consult
their GP should their symptoms remain troublesome.
Randomisation sequence generation, allocation
concealment, implementation
Randomisation will be completed at the Arthritis
Research UK Primary Care Centre by administrative
staff with no clinical involvement in the trial. Details of
participants eligible for randomisation will be passed to
Centre administrative staff by the research nurse after
each research clinic. Administrative staff will enter
details of those eligible for randomisation into a Micro-
soft ACCESS database (housed in a separate geographi-
cal location to where the clinical assessments will be
conducted). Randomisation will be implemented using
random permuted blocks of size 4. The blocks will be
selected at random using a random number generator
within the ACCESS database and will be selected sepa-
rately for each GP practice. The randomised treatment
of the next patient in the trial will be concealed to both
administrative and OT staff until the point of randomi-
sation. Randomisation will be completed using an allo-
cation ratio of 1:1:1:1.
Blinding/masking
During the data collection phase, both the trial nurse and
treating OTs will be blind to the block size used in the
randomisation procedure. The research nurse will remain
blind to treatment allocation until all data collection
(including baseline and follow-up) has been completed.
Success of blinding will be recorded by the research
nurse in the clinic assessment at 6 months and during
MDC over the telephone. The trial statistician will be
blind to treatment allocation until the main treatment
analysis has been completed.
To ensure the nurse and trial statistician remain blind
to treatment allocation the following will be observed:
• The password for the database and where it is to
be stored will not be known by the statistician.
• Treatment arms in the treatment database will
always be stored as ABCD and the key to un-blind
the treatments will only be known by the database
designer and administrative staff executing the
randomisation.
• The research nurse will emphasise to participants
at the 6-month clinic assessment that they should
not reveal what treatment they have received.
• The nurse will not have access to any of the data-
bases. Any information passed to the research nurse
(such as participant name, address and appointment
time) will be done via the administrative assistant.
• Consent to participate in the trial will be done by
the research nurse who will be unaware of which
treatment the patient has been randomised to
receive.
Research nurse training
To ensure standardisation, three qualified research
nurses will receive training in the use of pre-defined
protocols for all components of the research assessment.
Training on using the protocols will be carried out prior
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to the clinic commencement and the protocols will be
described in a Research Nurse Assessment Manual
which will be available for use throughout the study per-
iod. A pilot study of the procedures using the training
manual will also be undertaken.
At regular periods throughout the study, audits will be
conducted to ensure quality and consistency of the
research nurse assessment.
Study Setting
The study will be conducted in primary care. The setting
will be general practices and OT outpatient facilities in
Central Cheshire and North Staffordshire, UK. The GP
practices, from which the participants will be recruited,
cover a heterogeneous population, both socio-economically
and geographically. The nurse assessment clinics will be
conducted in GP practices and OT departments in local
NHS hospitals. Those conducted in OT departments will
be carried out in different areas and at different times to
the OT interventions. Each clinic will be staffed by a
research nurse who will be assisted by receptionists
employed by the GP practice or NHS. Two sites in North
Staffordshire and Central Cheshire will deliver all 3 OT
interventions.
Training of Occupational Therapists
OTs delivering the intervention will initially participate
in two consensus workshops to determine the most rele-
vant, evidence-based, joint protection principles and
hand exercises for use in hand OA. A literature review
and analysis of evidence for joint protection and hand
exercises for hand OA and RA will identify a range of
principles and exercises that may be used in practice.
The OTs will then be asked to identify up to 10 key
joint protection and energy conservation principles con-
sidered relevant for hand OA (for example, ‘distribute
load over several joints’, ‘modify environment to support
ergonomic/joint protection principles’) and to identify
key range of movement and strengthening exercises for
the fingers, thumb and hand.
A pool of 12 OTs (2 groups of 6), with a particular
interest or expertise in hand OA, will be given two days
training at a local OT hospital site by the leader of the
OT programme (AH). The OTs will be trained in the
principles of patient education and factors affecting
adherence and behaviour, including the principles of
self-efficacy [34], prior to being introduced to the joint
protection and hand exercise programme. The joint pro-
tection and hand exercise programmes will use Self-Effi-
cacy Theory [34], the Health Belief Model [35], self-
management cognitive-behavioural theory [36], motor
learning and adult education as their basis, and will
focus on addressing specific factors to support the use
of joint protection techniques and hand exercises.
OTs will have the opportunity to practice teaching
techniques, joint protection methods and hand exercises.
Further details of the programme will be available from
the Principal Investigator (KD).
Interventions
There will be four treatment arms to the study; leaflet
and advice; joint protection delivered by an occupational
therapist in a group setting; hand exercises delivered by
an occupational therapist in a group setting; and joint
protection combined with hand exercises delivered by
an occupational therapist in a group setting.
Previous studies suggest that people with hand OA do
not consult their GP very often about their symptoms and
adopt their own approaches to self-management, which
may or may not have beneficial effects. In order to stan-
dardise information given to participants, all eligible parti-
cipants will receive information on GP headed notepaper
from a research nurse prior to randomisation. Participants
will be instructed to continue with their own self-manage-
ment approaches, which they will be asked to record, will
receive standardised advice on the use of analgesia and
will be given the Arthritis Research UK leaflets ‘Osteoar-
thritis’ and ‘Looking after your joints when you have
arthritis’ http://www.arthritisresearchuk.org. Relevant sec-
tions in the booklets will be highlighted and discussed. A
leaflet on GP headed notepaper, which includes general
information on looking after the joints of the hand, how to
use the leaflets, and advice to consult their GP if symp-
toms continue to be troublesome, will be provided. Partici-
pants will also receive NICE good practice guidance [37]
and advice on effective pain management with the use of
paracetamol as first line analgesia, and advice on when to
consult their GP. Co-interventions will be recorded and
avoided during the first six months of the study.
Leaflet and advice The intervention will be delivered as
described above without any additional OT classes.
OT Interventions Participants randomised to any one of
the OT interventions will receive in addition to the
above, four group sessions held once a week with 4-6
participants. A pool of 12 OTs will be trained to deliver
the interventions. In order to develop rapport between
participants and therapist it is planned that the same OT
will conduct all four sessions. Non-trial co-interventions
e.g. splinting, will be avoided during the first six months
of the study and recorded if given. To reduce any poten-
tial bias, each OT will rotate throughout the interventions
every three months. Rotation will be determined by the
availability of the OTs to deliver the specific intervention,
that is, the single component interventions, or the com-
bined programme.
All three OT interventions will include a general
introduction, education on hand OA and its manage-
ment, and management of pain during everyday activ-
ities. The OT interventions will be supported by leader
and participant manuals which will be used to promote
treatment adherence and to standardise delivery of the
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OT interventions. Flipcharts will be used as teaching
aids, which will identify key points to be addressed
within each session, and copies of the pre-written charts
will be included in the leader manuals.
Participants will be encouraged to practice techniques
taught in the sessions and illustrated in the participant
manual, by setting weekly action plans, homework pro-
grammes and weekly review of progress. Participants
will be encouraged to continue with their own self-man-
agement approaches, which they will be asked to record
in their participant manual.
Joint protection classes
The OT intervention will be based on that previously
used in inflammatory arthritis and adapted for hand
OA, with particular attention to hand and thumb pro-
blems [11,12]. Supervised kitchen activities will be
undertaken with participants in pairs to allow demon-
stration and practice of new skills. Classes will be deliv-
ered over 4 group sessions (maximum 1 hour each
session).
Hand exercise classes
Hand exercises to strengthen muscles and mobilise
joints will be developed from those identified in the
consensus workshops. These will form the basis of the
exercise classes which will be demonstrated and prac-
tised with participants seated around a large table.
Classes will be delivered over 4 group sessions (maxi-
mum 1 hour each session).
Joint protection with hand exercises
Participants will receive both joint protection and hand
exercises over 4 group sessions (maximum 11/2 hours
each session).
Attendance protocol
The OT will be faxed a copy of the participant consent
and a standard proforma prior to each session. The pro-
forma will contain the participant identifier, the type of
intervention to be delivered and the session number. At
each class, the OT will confirm these details, indicate
whether participants have attended and then fax the
form to the study co-ordinator (SH) who will then audit
adherence to the attendance protocol. The OTs will
record the type of intervention received by each partici-
pant and the length of time of each treatment session
on the proforma. Participants will be required to attend
a minimum number of sessions. Participants failing to
attend session 1 will be invited to attend session 1 of a
subsequent round. Session 4 will be designed to sum-
marise the content of the previous sessions. Participants
failing to attend session 4, and not having completed
sessions 2 and 3, will be invited to session 4 in a later
round. Participants failing to attend session 2, 3 or both,
will only be invited to repeat the missed sessions if
requested by the OT or participant.
Audit of OT interventions
In addition to the standard proforma, an audit for the
group intervention will be devised based on the leader
manuals. The study co-ordinator will use these to carry
out random audits to assess adherence to the interven-
tion protocol.
Monitoring and reporting of harms
If a patient experiences an adverse event the OT con-
cerned will inform the study coordinator by fax or tele-
phone. The co-ordinator will investigate and record all
details of the incident on an “adverse event” form. The
Principal Investigator will be notified of the event, and
will determine any follow-up action as required, e.g.
referral to the participant’s GP. All adverse events will
be reported to the Data Monitoring Committee and the
Trial Steering Committee.
Equipment
All OT sites will be provided with a standardised equip-
ment package for the delivery of the joint protection
and exercise programmes. An equipment inventory is
available on request from the study co-ordinator.
Electronic OT mailing list
In order to enhance protocol adherence and to offer
support to the OTs involved in the trial, the Principal
Investigator and study co-ordinator will set up a shared
electronic mailing list for participating therapists.
Pilot study
Up to 6 participants will be invited to attend a pilot
study of the OT intervention. These participants will be
members of the Centre Research Users Forum and will
have a history of hand OA. The pilot study will be
based on the combined programme of hand exercises
and joint protection, and will take place at a local OT
Department. The study will test processes and proce-
dures, and any further amendments to the content of
the intervention will be made prior to the commence-
ment of the main trial.
Data collection management and analysis
Primary outcome measure
Study outcomes are documented in Tables 4 and 5, and
are based on previously validated measures [38,39]. The
primary outcome will combine pain and function sub-
scales of the AUSCAN [31,40] and global assessment of
improvement [41] to determine a ‘responder’ using the
OARSI-OMERACT criteria [42] at 6 months post rando-
misation. Response options for the AUSCAN items are
on a 5-point scale ranging from none to extreme, and for
the purpose of this study the AUSCAN validated for use
in older adults with hand pain in the population will be
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Table 4 Secondary outcome measures
Outcome Measurement Scale Time points
AUSCAN pain [31,40] 0-20 HS, 0Q, 3, 6Q, 12, +
AUSCAN stiffness [31,40] 0-4 HS, 0Q, 3, 6Q, 12, +
AUSCAN function [31,40] 0-36 HS, 0Q, 3, 6Q, 12, +
Total AUSCAN [31,40] 0-12 HS, 0Q, 3, 6Q, 12, +
Pain severity in the last 3 days NRS: 0-10 0NA, 3, 6NA, 12
Severity of participant nominated worse problem in the last
3 days [44]
NRS: 0-10 0NA, 3, 6NA, 12
Satisfaction with hand function in the last 3 days NRS: 0-10 0NA, 3, 6NA, 12
Power grip (JAMAR dynomometer) [33] lbs 0NA, 6NA
Pinch grip (B&L pinch gauge) [33] lbs 0NA, 6NA
Grip-ability test (GAT) [32] Timed (seconds) 0NA, 6NA
Short-form 12 (SF-12): physical and mental health
component scores [49]
0-100 HS, 0Q, 3, 6Q, 12
Arthritis self efficacy for pain [50] 1-10 HS, 3, 6Q, 12
Global assessment of change in hand problem [41] Completely recovered/much better/better/no change/worse/
much worse
3, 6Q, 12, +
NRS = Numerical rating scale; HS = Baseline Health Survey; 0Q = Baseline Questionnaire; 0NA = Baseline nurse assessment; 3 = 3-month questionnaire; 6Q = 6-
month questionnaire; 6NA = 6-month nurse assessment; 12 = 12-month questionnaire; + = included in minimum data collection.
Table 5 Tertiary outcome measures
Outcome Measurement Scale Time points
Demographic variables
Age Years HS, 0Q, 3, 6Q,
12, +
Gender Female/Male HS, 0Q, 3, 6Q,
12, +
Marital status Married/Separated/divorced/widowed/cohabiting/single HS
Employment status Working full time/working part time/working full time in the home/
unemployed or seeking work/not working due to ill health or disability/
student/retired
HS
Social class [65] Higher managerial/Higher professional/Lower managerial or professional/
Intermediate occupations/Self employed/Lower supervisory or technical/
Semi-routine/Routine
HS, 0NA
Age when left school Years HS
Leave school to go to full-time education or university Yes/No HS
Age when finished full time education Years HS
Gained qualifications through study as an adult Yes/No HS
Ethnic origin White UK or European/AfroCaribbean/Chinese/Asian
/African/Other
HS
Height Feet and inches or centimetres HS
Weight Stones and lbs or kilograms HS
Measures to define trial inclusion/exclusion
Hand pain in the last year Yes/No HS
Pain, aching or stiffness in your hands in the last month
[30]
No days/Few days/Some days/Most days/All days HS, 0Q, 0NA,
3, 6NA, 12
Seen OT or PT for hand problem in last 6-months No/Right hand only/Left hand only/Both hands HS, 0NA1
Injured hands badly enough to see a doctor in last 6
months
No/Right hand only/Left hand only/Both hands HS, 0NA1,
6NA
Had a hand operation in the last 6 months No/Right hand only/Left hand only/Both hands HS, 0NA1,
6NA
Joint injection (fingers, thumbs or wrist) in the last 6
months
No/Right hand only/Left hand only/Both hands HS, 0NA1
Clinical red flags (e.g. swollen painful hot hands or
recent trauma to the hands)
Yes/No 0NA, 6NA
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Table 5 Tertiary outcome measures (Continued)
Clinical assessment for hand swelling, nodes,
enlargement or deformity
Yes/No for joints required to apply the ACR criteria for hand OA (ref) 0NA
Characteristics of hand problem
Handedness Right/Left/Both HS, 0NA, 6NA
Hand problems in the last year Yes/No HS
Hand pain location in the last year Right/Left/Both HS, 0NA2,
6NA2
Hand pain manikin [43] Hand area shaded to represent pain 0Q, 3, 6Q, 12
Hand that gives most problem Right/Left/No difference HS, 0NA, 6NA
Number of days with hand pain in the last year [66] Less than 7 days/1 to 4 weeks/> 1 month and < 3 months/3-months or
more
HS
Hand pain severity in the last month NRS: 0-10 (no pain to pain as bad as could be) 0Q
Bothersomeness of hand problems (adapted from [67]) Not at all/slightly/moderately/very much/Extremely 0Q, 3, 6Q, 12
Thumb pain during activity in the last month Yes/No 0NA, 3, 6NA,
12
Ability to make a fist [68] Right: yes/no/unable; Left: yes/no/unable 0NA, 6NA
Length of time with a hand problem HS-years
0NA-Separate response for right and left hand
< 12 months/1 to 5 yrs/5 to 10 yrs/10+ yrs
HS, 0NA
Previous hand surgery Operation details, which hand, timing (< 1 yr ago/1 to 5yrs ago/5 to 10yrs
ago/10+ yrs ago)
0NA, 6NA3
Previous hand injury Injury details, which hand, timing (< 1 yr ago/1 to 5yrs ago/5 to 10yrs
ago/10+ yrs ago)
0NA, 6NA3
Past or present job involved excessive use of hands Yes/No HS
Past or present hobbies or pastimes involved excessive
use of hands
Yes/No HS
Global assessment of change in hand pain since
baseline [41]
Completely recovered/much better/better/no change/worse/much worse 3, 6Q, 12
Global assessment of change in ability to use hands
since baseline [41]
Completely recovered/much better/better/no change/worse/much worse 3, 6Q, 12
Body pain and shoulder function
Pain elsewhere (body manikin) Body area shaded to represent pain lasting for a day or longer in the last
4 weeks
HS, 3, 6Q, 12
Ability to put hands behind head [68] Right: yes/no/unable; Left: yes/no/unable 0NA, 6NA
Perception, impact and quality of life
Illness perceptions Subset of questions from the illness perceptions questionnaire revised
(IPQ-R) [45,51]
HS, 0Q, 3, 6Q,
12
Participation restriction (selected questions from [46]) All the time/most of the time/some of the time/A little of the 0Q, 3, 6Q, 12
- Self-care needs met as and when wanted time/None of the time
- Home looked after as and when wanted
- Belongings looked after as and when wanted
Hand problems make you feel frustrated in the last
month [45]
All days/most days/some days/few days/no days 0Q, 3, 6Q, 12
Adaptation behaviours 0NA, 6NA
- Use gadgets Yes/No to each question
- Help from another person
- Avoidance
- Find a different way of doing something
- Stopping/reducing activities
- Things take longer
- Other (please state)
Quality of life: EuroQol-EQ5-D [47,48] (-0.59-1) 0Q, 3, 6Q, 12
Intervention evaluation
Satisfaction with care received for hand problem Very satisfied/Quite satisfied/no opinion/not very satisfied/not at all
satisfied
3, 6Q, 12
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used [40]. Global assessment of improvement is on a 6-
point scale ranging from completely better to much
worse.
Minimum data collection at each follow-up data col-
lection stage will attempt to capture the primary out-
comes, AUSCAN and global change scores, in the event
of non-response to the mailed follow-up questionnaire.
Secondary and tertiary outcome measures
Self-reported questionnaire at baseline, 3, 6 and 12
months Individual subscales of the AUSCAN (pain, stiff-
ness and function), hand pain manikin [43], average pain
severity over the past 3 days (0-10 numerical rating
scale), severity rating of participant nominated main
functional problem over the past 3 days (0-10 numerical
rating scale) [44], satisfaction with hand function over
the past 3 days (0-10 numerical rating scale), side effects
of treatment and adverse events, co-interventions (from
the medical record download: follow-up visits to the GP,
prescription of medication including NSAIDs and refer-
ral for other treatment such as surgery and from self-
reported questionnaires: self-help remedies, contacts
with private healthcare, over the counter medicines, use
of hand splints), frustration related to hand disability
[45], pain elsewhere (pain manikin), participation
restriction [46], health-related quality of life using the
EuroQol EQ-5D [47,48] and SF12v2 [49], satisfaction
with care (3 and 6 months), Arthritis Self Efficacy pain
subscale [50], Illness Perceptions Questionnaire-Revised
(IPQR) modified for hand OA [45,51] and self-reported
behaviour change using selected questions [52].
Table 5 Tertiary outcome measures (Continued)
Treatment sessions: Number of appointments Too many/About right/Not enough/I did not attend any appointments 3
Treatment sessions: Length of each visit Too long/About right/Too short/I did not attend any appointments 3
Hand exercise frequency [69] Never/Once a week/Twice a week/Three times a week/Four times a week/
Five times a week/Six times a week/Once every day/Twice every day
6Q, 12
Hand exercise frequency in last week [52] Never/Almost never/Sometimes/Fairly often/Very often/Always 0Q, 3, 6Q, 12
Hand exercise duration [69] < Five minutes/5-10 minutes/10-15 minutes/15-30 minutes/30 minutes+/I
don’t do hand exercises
6Q, 12
Behaviour change in last week: energy conservation/
fatigue [52]
(1-6) i.e. average of 5 items each rated as: Never/Almost never/Sometimes/
Fairly often/Very often/Always
0Q, 3, 6Q, 12
- Regular breaks
- Breaking up tasks
- Pacing of activities
- Swapping between light and heavy tasks
- Maintaining good posture whilst sitting, standing,
lifting objects or moving about
Behaviour change in last week: joint protection use [52] (1-6) i.e. average of 5 items each rated as: Never/Almost 0Q, 3, 6Q, 12
- Use two hands to carry things never/Sometimes/Fairly often/Very often/Always
- Avoid gripping or pinching things tightly
- Change the way everyday activities are completed
- Use gadgets/labour-saving devices
- Use stronger, larger joints
Behaviour change in last week: carry on working
through the pain when doing everyday activities [52]
Never/Almost never/Sometimes/Fairly often/Very often/Always 0Q, 3, 6Q, 12
Health care use and co-interventions
Self-report Self-help remedies, contact with NHS and private healthcare, over the
counter medicines, use of hand splints
HS, 0NA, 6Q,
6NA, 12
GP consultation download Number of follow-up visits to the GP, prescription of medication including
NSAIDs and referral for other treatment such as surgery
Continually
collected data
Nurse audit questions
Did the participant un-blind you during the
assessment?
Yes/No 6NA
If yes, what did the participant say and could it have
been avoided?
Text 6NA
If yes, what treatment arm do you think the patient is
randomised to
Leaflet and advice/Had OT, but not sure which OT intervention/Had OT,
joint protection/Had OT, hand exercises/Had OT, joint protection and hand
exercises
6NA
NRS = Numerical rating scale; OT = occupational therapist; PT = Physiotherapist; HS = Baseline Health Survey; 0Q = Baseline Questionnaire; 0NA = Baseline nurse
assessment; 3 = 3-month questionnaire; 6Q = 6-month questionnaire; 6NA = 6-month nurse assessment; 12 = 12-month questionnaire; + = included in minimum
data collection; 1 = time frame last month; 2 = refers to current hand problem; 3 = time frame last 6 months.
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Clinical assessment at baseline and 6 months only
grip strength (JAMAR) [33], pinch strength (B & L
pinch gauge) [33], functional performance using the grip
ability test (GAT) [32]. (See Tables 4 and 5).
Diary
All participants randomised to the trial will be given a
diary to complete at baseline (nurse clinical assessment)
and at 6 months (the primary end point). The diary is
based upon the Activity Record (ACTRE) for patients
with musculoskeletal disorders [53,54]. The diary aims
to capture hand pain and functional limitation experi-
enced when carrying out main activities for each half
hour during a typical weekday and a weekend day, along
with any rest periods taken during the activities. For
each main activity, in each half hour period, participants
will rate their hand pain and hand disability on a 0-3
scale, where 0 represents ‘no hand pain/disability’ and 3
represents ‘a lot of hand pain/disability’. The 6-month
diary will also include open ended questions to ask par-
ticipants if they feel they have benefitted from taking
part in the study and if not what they feel would have
been beneficial. Participants will also be invited to make
any additional comments if they wish.
Target sample size
The main study sample size calculation will be based on
the comparison of participants receiving and those not
receiving hand exercises. The calculation would be iden-
tical for the comparison of joint protection versus no
joint protection, as hand exercises and joint protection
are assumed equally effective and independent treat-
ments [55].
In participants not receiving hand exercises 50% will
receive a leaflet and advice, and 50% will receive joint
protection. We estimate that 25% of participants in the
leaflet and advice group will improve using the OARSI-
OMERACT responder criteria and 45% will improve in
the joint protection group [42,56]. This gives a com-
bined improvement of 35% in participants not receiving
hand exercises, assuming equal allocation of participants
between treatment groups.
Published information is not available to define a
minimum clinical important difference for the primary
outcome measure. Therefore, after a consensus discus-
sion with the OTs we estimate this at 20%, and hence
the estimate of improvement in the group who receive
hand exercises to be 55% (i.e. 35% + 20%). To detect a
difference of 20% or larger between participants receiv-
ing and those not receiving hand exercises, with 80%
power and alpha of 5%, a total of 212 participants with
data at baseline and at 6 months are required. To allow
for a 15% drop-out over the 6 months post randomisa-
tion period, 252 participants will be randomized, i.e. 63
per treatment arm.
Statistical methods, between group comparisons, handling
of non-adherence and missing data
The main statistical analysis will be based on reporting
guidelines for the design and conduct of factorial trials
[55] and will be conducted for all primary and secondary
outcomes. The main treatment analysis will be conducted
blinded to treatment allocation and will be analysed on an
intention to treat basis with all randomised participants
retaining their original randomised group. Outcome mea-
sures that are continuous will be analysed using analysis of
covariance (ANCOVA); for binary outcomes, logistic
regression will be used. The data will be analysed at 3, 6
and 12 month follow-up, however, 6 months is the pri-
mary end point for the study.
An initial treatment model will be fitted (for each pri-
mary and secondary outcome and end-point) to predict
the outcome of interest and will include the two treatment
effects of interest: no joint protection versus joint protec-
tion; no hand exercises versus hand exercises, and their
interaction. If the interaction term is not statistically signif-
icant (p > = 0.05) it will be dropped from the model. The
model will be re-run, and the treatment effects for joint
protection and hand exercises determined individually
from this model, either as mean differences or odds ratios
with associated 95% confidence intervals, as appropriate. If
the interaction term is statistically significant (p < 0.05),
the effect of joint protection and hand exercises will be
evaluated from a model with treatment represented as a 4-
level variable (i.e. leaflet and advice, joint protection, hand
exercises, joint protection and hand exercises) and the
reduced statistical power of this model noted. This model
will also be used as a secondary analysis to compare the
effectiveness of the individual treatments to the leaflet and
advice arm.
All analysis models will be adjusted for the baseline
value of the outcome of interest (with the exception of
the OARSI/OMERACT responder criteria which is not
computable at baseline) and also for age, gender, social
class, length of time with a hand condition and general
practice (covariates defined a priori as those that may
influence treatment outcome). Missing data will be
imputed using the multiple imputation routines in
STATA version 11.0 [57].
A sensitivity analysis will be completed to examine the
effectiveness of joint protection and hand exercises for
those participants attending all four treatment sessions.
This analysis will only be completed if there are suffi-
cient participants attending all four treatment sessions.
Treatment concordance will also be evaluated descrip-
tively by (self-reported) frequency and duration of hand
exercise completion at 3-, 6- and 12-month follow-up.
Generalisability of the trial findings and the success of
the randomisation procedure will be explored descriptively
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by comparing key characteristics of participants at recruit-
ment and each follow-up stage and for each randomised
treatment arm. No interim analyses will be planned during
the trial follow-up period.
Health economics
The purpose of economic evaluation is to inform deci-
sion makers about competing claims for health care
resources. Uncontaminated estimates of costs and effects
of alternative treatments are the key parameters for the
provision of cost effectiveness evidence and, accordingly,
the clinical analytic framework for factorial design ran-
domised controlled trials is not suitable because of the
combination of treatment regimens.
The estimation of cost-effectiveness within this 4-arm
study will focus on the principles of dominance and
extended dominance. Dominance is a straightforward
concept; if an intervention is less effective and more
costly than at least one of its comparators, it is not for
further consideration with regard to the estimation of
cost-effectiveness. Extended dominance is applied in
incremental cost-effectiveness analysis when an inter-
vention is less effective and more costly than a linear
combination of two other strategies; the purpose is to
remove from consideration those strategies whose costs
and benefits are improved by a mixed strategy of two
other alternatives [58]. The practical application of cost-
effectiveness analysis is to compare an intervention with
the next most effective strategy; failure to remove all
dominated or extendedly dominated strategies may lead
to comparisons that are not with the next best alterna-
tive but with irrelevant alternatives.
In the base case analysis, the estimation of costs relat-
ing to the UK National Health Service (NHS) will be
based on responses to health care resource use questions
within the 6-month and 12-month postal questionnaires;
responses will be aggregated to generate a 12-month cost
estimate for each responder. The resource use questions
will capture details covering a broad range of health care
resources, including prescribed medications, primary
care and secondary care (inpatient and outpatient) atten-
dances, treatments and investigations. The primary unit
of benefit is the quality-adjusted life year (QALY), calcu-
lated by applying area-under-the-curve techniques to
EuroQol EQ-5D index scores at baseline, 3 months, 6
months and 12 months [59]. The EQ-5D is a generic
health status measure that provides utility values for all
possible responses to the 5-dimension questionnaire
based on health state valuations elicited from a large
representative sample of the UK population [60]. The
values range from 1.00 (no problems on all dimensions)
to -0.59 (severe or extreme impairment on each dimen-
sion). Accordingly, the maximum number of QALYs per
patient is equal to 1 (equivalent to 12 months spent in
full health), with QALYs less than 1 reflecting less than
perfect health. Following the identification of appropriate
pair-wise comparisons through extended dominance
principles, differences in costs and QALYs will be
expressed using the incremental cost-per-QALY ratio.
This ratio measure provides an estimate of the additional
cost necessary to generate one additional QALY. Multi-
ple imputation techniques will be used to deal with miss-
ing EQ-5D scores and resource use data, ensuring that all
eligible trial participants are included in the base case
economic evaluation [61,62].
Probabilistic sensitivity analysis will address uncertainty
around the incremental ratio through the application of
bootstrap techniques to generate cost-effectiveness planes
and acceptability curves [63,64]. Further sensitivity analysis
will explore the robustness of the results to variation in
key parameters and methodological techniques; namely,
the adoption of alternative costing methodologies (e.g.
‘generic’ verses ‘hand OA-specific’ health care resource
use), a broader analytic perspective that incorporates costs
beyond those attributable to the UK NHS, a complete-
case analysis to consider the implications of missing data,
and the impact of using different generic health status
measures to provide utility values.
Trial monitoring
The research centre’s independent Data Monitoring
Committee (DMC) will monitor the study 6-monthly
and reports will be written in line with Arthritis
Research UK recommendations (http://www.arthritisre-
searchuk.org). The independent DMC has also agreed to
act as the trial steering committee.
Research Ethics
Ethical approval was obtained from the Central Manche-
ster Research Ethics Committee, UK on 21st February,
2008 [ref number 07/H1008/235]. Any subsequent
amendments will be reported in the DMC reports.
Discussion
There is limited evidence for the clinical and cost effec-
tiveness of OT approaches in the management of OA
despite the important role that OTs play in the treat-
ment of people with hand OA. Joint protection and
hand exercises have been proposed by European guide-
lines for hand OA [13]. However, the clinical and cost
effectiveness of each intervention and the combined
approach is unknown.
This protocol outlines the SMOotH study, a multicentre
two-by-two factorial randomised controlled trial in com-
munity-dwelling older adults. The aims are (i) to compare
the effectiveness of joint protection delivered by an OT
with no joint protection, (ii) to compare the effectiveness
of hand exercise delivered by an OT with no hand exer-
cises and (iii) to determine which of the four management
approaches explored within the study (leaflet and advice,
joint protection, hand exercises, or joint protection and
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hand exercise combined) provides the most cost-effective
use of health care resources.
Findings from this study will contribute to the cost-
effective evidence based management of hand OA and
to existing recommendations published by EULAR.
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